FEB 26, 2015 08:39 AM PST

New Clues for Treatment of Antibiotic-Resistant Bacteria

WRITTEN BY: Judy O'Rourke
Researchers at the University of Georgia have identified a previously unknown process that many bacteria, including those that cause disease in humans, use to survive. Their discovery could lead to new therapies for bacterial infections like MRSA and tuberculosis that are resistant to current antibiotic treatments.

Their discovery centers on the ways in which bacteria use an iron compound known as heme. Most commonly recognized as a fundamental component of hemoglobin-the red pigment in blood responsible for the transportation of oxygen-heme also provides some of the essential nutrition that bacteria require to grow within a host.
Heme
"We found an enzyme that only gram-positive bacteria have, and they use this enzyme in a unique way to make heme," says Harry Dailey, PhD, professor of microbiology and lead author of the paper describing their discovery in the Proceedings of the National Academy of Sciences. "Heme is essential for these organisms; they have to make heme, so if we can find a way to disrupt this process, the bacteria would die."

More than 2 million people become infected with bacteria that are resistant to antibiotics each year in the United States, and at least 23,000 people die as a direct result of these infections, according to the Centers for Disease Control and Prevention.

The enzyme discovered in Dailey's lab could serve as an attractive target for the next generation of antibacterial drugs, and his laboratory is partnered with other institutions to explore the development of new therapeutics.

"One of the great things about this enzyme in terms of treatment is that it is only found in gram positive bacteria-it's not found anywhere else," says Dailey, who's also director of UGA's Biomedical and Health Sciences Institute. "So if you target the enzyme with a therapeutic, you won't damage any of the other essential mechanisms that we need to remain healthy."

Their discovery also challenges some of the established scientific literature related to the production of heme, which has remained largely unchanged for decades.

"We are obviously very excited about the potential medical applications related to this enzyme, but our experiments also tell us a lot about the evolutionary history driving the behavior of organisms we study every day," Dailey says. "We have assumed for more than 50 years that we understood these pathways well, but it may not be as clear cut as we once thought."

A version of the paper as it appeared in PNAS is titled "Noncanonical coproporphyrin-dependent bacterial heme biosynthesis pathway that does not use protoporphyrin."

[Source: University of Georgia]
About the Author
  • Judy O'Rourke worked as a newspaper reporter before becoming chief editor of Clinical Lab Products magazine. As a freelance writer today, she is interested in finding the story behind the latest developments in medicine and science, and in learning what lies ahead.
You May Also Like
SEP 20, 2018
Videos
SEP 20, 2018
The Lowdown on Vaccine Development and Production
Learn more about how vaccines are developed and tested, from the CDC....
OCT 02, 2018
Videos
OCT 02, 2018
Learning how Bacterial Chemicals Impact Human Health
We play host to a huge number of microbes, and all the chemicals that they produce....
OCT 07, 2018
Videos
OCT 07, 2018
Certain Foods Encourage a Gut Microbe, and Colon Cancer
Researchers reveal more evidence that refined grains and sugars and processed meats are bad for colon health....
OCT 08, 2018
Microbiology
OCT 08, 2018
Is a Virus Causing a Mysterious Polio-like Illness in Kids?
Sometime in 2014, the CDC began to get reports of a mysterious illness that was affecting children. More cases have appeared since then....
NOV 09, 2018
Cardiology
NOV 09, 2018
Lyme Disease And The Heart
In small-town New England, everyone knows the unique characteristic symptom of Lyme disease. A bulls-eye pattern rash around a tiny tick bite, infection gr...
NOV 25, 2018
Drug Discovery
NOV 25, 2018
Advancing Drug Therapies for an Increasing Case of a Parasitic infection Among Displaced Syrians
Cases of Cutaneous leishmaniasis (CL), a parasitic disease, has increased dramatically in Syria and neighboring countries as a result of the conflict-relat...
Loading Comments...